VISION STATEMENT

Our vision is to improve women’s reproductive health in Africa, by developing innovative approaches to prevent and treat bacterial vaginosis (BV) that is relevant to resource-limited settings.

Our aim is to establish an African-lead “vaginal microbiome biorepository” that can be used to develop new live biotherapeutic products to treat BV, by exploiting health-promoting properties of Lactobacillus crispatus strains from women in Africa with persistently healthy vaginal communities as well as understanding disease-associated properties of the pathobionts that cause BV.